Poster & Publications

Improve Molecular Residual Disease monitoring by combining ctDNA molecular profiling and circulating H3K27Me3-nucleosome levels

March 05, 2024

Share
Tweet
Share on Facebook
Share

Poster titled: “Improve Molecular Residual Disease monitoring by combining ctDNA molecular profiling and circulating H3K27Me3-nucleosome levels in NSCLC plasma samples.”

Presented at CNAPS 2024

Grolleau et al

Download

Poster & Publications
EZH2 inhibition enhances the activity of Carboplatin in aggressive-variant prostate cancer cell lines
Blog
Lung cancer awareness month

Share
Tweet
Share on Facebook
Share

Subscribe for Volition product updates.

Or, click here for Investor Updates and press releases.

"*" indicates required fields

Receive product updates for:

Animal Health

Human Health

Name*

First Name Last Name

Company Name*

Your Email Address*

CAPTCHA

Improve Molecular Residual Disease monitoring by combining ctDNA molecular profiling and circulating H3K27Me3-nucleosome levels

Related Articles

EZH2 inhibition enhances the activity of Carboplatin in aggressive-variant prostate cancer cell lines

Lung cancer awareness month

Subscribe for Volition product updates.

Or, click here for Investor Updates and press releases.

Contact